secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001140361-24-043250
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics affirms 2024-2025 guidance unaffected by auditor switch
----------------------------------------------------------------------

- Management stated no anticipated impact to previously provided 2024-2025 financial guidance from auditor transition.
- Statement made after market close on Oct 9, 2024, in discussions with analysts.
- Auditor change described in separate Form 8-K filed on Oct 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124043250/0001140361-24-043250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124043250/ef20037117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-043250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer